Howard Yu-Hao Liu (Howard Y Liu, H Y Liu, Howard Liu)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Journal of medical imaging and radiation oncology

Head & neck

Cancer immunology, immunotherapy : CII

Current oncology (Toronto, Ont.)

Princess Alexandra Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Princess Alexandra Hospital

Australia

Staff Specialist, Radiation Oncology :: Radiation Oncology

Publications

Howard Yu-Hao Liu, Nicholas Hardcastle, Michael Bailey, Shankar Siva, Anna Seeley, Tamara Barry, Jeremy Booth, Louis Lao, Michelle Roach, Stacey Buxton, David I Thwaites, Matthew Foote
Guidelines for safe practice of stereotactic body (ablative) radiation therapy: RANZCR 2023 update. Journal of medical imaging and radiation oncology (2023)
Howard Yu-Hao Liu, Nicholas Hardcastle, Michael Bailey, Shankar Siva, Anna Seeley, Tamara Barry, Jeremy Booth, Louis Lao, Michelle Roach, Stacey Buxton, David I Thwaites, Matthew Foote
Guidelines for safe practice of stereotactic body (ablative) radiation therapy: RANZCR 2023 update. Journal of medical imaging and radiation oncology 68 (2) (2023)
Beini Chen, Nick Butler, Thomas O'Rourke, Peter Hodgkinson, Katherine Stuart, Edwin Shih, David Leggett, David I Pryor, Howard Yu-Hao Liu, Dominique Lee
Refining stereotactic body radiation therapy as a bridge to transplantation for hepatocellular carcinoma: An institutional experience. Journal of medical imaging and radiation oncology (2023)
Howard Yu-Hao Liu, Nicholas Hardcastle, Michael Bailey, Shankar Siva, Anna Seeley, Tamara Barry, Jeremy Booth, Louis Lao, Michelle Roach, Stacey Buxton, David I Thwaites, Matthew Foote
Guidelines for safe practice of stereotactic body (ablative) radiation therapy: RANZCR 2023 update. Journal of medical imaging and radiation oncology 68 (2) (2023)
Benjamin Chua, Pereshin Moodaley, Wei Soon, Howard Yu-Hao Liu, Yoo Young Lee, David I Pryor
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes. Journal of medical imaging and radiation oncology 65 (7) (2021)
Howard Yu-Hao Liu, Yoo-Young Dominique Lee, Swetha Sridharan, Ee Siang Choong, Hien Le, Wei Wang, Richard Khor, Julie Chu, Andrew Oar, Rebekah Mott, Joanne Smart, Trish Jenkins, Nigel Anderson, Shamira Cross, Kee Fong Loo, Alan Wigg, Katherine Stuart, David I Pryor
Stereotactic body radiotherapy in the management of hepatocellular carcinoma: An Australian multi-institutional patterns of practice review. Journal of medical imaging and radiation oncology 65 (3) (2021)
Arslan Babar, Neil M Woody, Ahmad I Ghanem, Jillian Tsai, Neal E Dunlap, Matthew Schymick, Howard Yu-Hao Liu, Brian B Burkey, Eric D Lamarre, Jamie A Ku, Joseph Scharpf, Brandon L Prendes, Nikhil P Joshi, Jimmy J Caudell, Farzan Siddiqui, Sandro V Porceddu, Nancy Lee, Larisa Schwartzman, Shlomo A Koyfman, David J Adelstein, Jessica L Geiger
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration. Current oncology (Toronto, Ont.) 28 (4) (2021)
Howard Yu-Hao Liu, Christopher P Daniels, Yuvnik Trada, Anne Bernard, Kyung Ha You, Elizabeth Brown, Matthew Foote, Margaret McGrath, Rahul Ladwa, Benedict James Panizza, Sandro Virgilio Porceddu
The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer. Head & neck 43 (5) (2021)
Sara W Liu, Neil M Woody, Wei Wei, Swathi Appachi, Kevin A Contrera, Jillian C Tsai, Ahmed I Ghanem, Brian Matia, Nikhil P Joshi, Jessica L Geiger, Jamie A Ku, Brian B Burkey, Joseph Scharpf, Brandon L Prendes, Jimmy J Caudell, Neal E Dunlap, David J Adelstein, Sandro Porceddu, Howard Yu-Hao Liu, Farzan Siddiqui, Nancy Y Lee, Shlomo Koyfman, Eric D Lamarre
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration study. Head & neck 43 (1) (2020)
Janin Chandra, W P Woo, N Finlayson, Howard Yu-Hao Liu, M McGrath, Rahul M Ladwa, M Brauer, Y Xu, S Hanson, Benedict J Panizza, Ian Hector Frazer, Sandro V Porceddu
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC). Cancer immunology, immunotherapy : CII 70 (3) (2020)

Howard Yu-Hao Liu.css-eqlu8i{font-size:small;padding-left:4px;} (Howard Y Liu, H Y Liu, Howard Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Howard Yu-Hao Liu (Howard Y Liu, H Y Liu, Howard Liu)